Insitro builds Physical AI on causal biology, combining 20+ petabytes of cellular experiments and population genetics to identify disease drivers and design medicines.
Products & media
Inside POSH: insitro’s automated robotic lab
CTRO-1013
An investigational liver-targeted siRNA designed to silence IRS1 as a potential treatment for metabolic liver disease.
Team
Jobs
See all jobs for Insitro here.
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Leads
Participating Firms
Angels
Series C
$400M
Series B
$143M
Series A
$100M
